Filing Details

Accession Number:
0001209191-11-038718
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-07-07 16:50:06
Reporting Period:
2011-07-05
Filing Date:
2011-07-07
Accepted Time:
2011-07-07 16:50:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1131096 Athenahealth Inc ATHN Services-Business Services, Nec (7389) 043387530
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1494174 H. Daniel Orenstein 311 Arsenal Street
Watertown MA 02472
Svp, Gc, And Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-07-05 596 $44.19 22,347 No 4 F Direct
Common Stock Disposition 2011-07-05 543 $42.00 21,804 No 4 S Direct
Common Stock Acquisiton 2011-07-05 533 $7.39 22,337 No 4 M Direct
Common Stock Disposition 2011-07-05 533 $42.00 21,804 No 4 S Direct
Common Stock Acquisiton 2011-07-06 1,000 $25.67 22,804 No 4 M Direct
Common Stock Disposition 2011-07-06 1,000 $46.00 21,804 No 4 S Direct
Common Stock Disposition 2011-07-07 1,279 $46.49 20,525 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2011-07-05 533 $0.00 533 $7.39
Common Stock Stock Option (Right to Buy) Disposition 2011-07-06 1,000 $0.00 1,000 $25.67
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2008-01-01 2017-03-15 No 4 M Direct
1,000 2010-01-05 2019-03-02 No 4 M Direct
Footnotes
  1. These shares were withheld to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the Reporting Person on August 2, 2010. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
  2. The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 4, 2011, in accordance with rule 10b5-1.